Published in Hepatitis Weekly, February 6th, 2006
"We evaluated clinical evolution and hepatitis B virus (HBV) molecular changes in heart recipients with chronic HBV infection before transplantation, and studied the effects of lamivudine treatment in patients who experienced HBV reactivation."
"Nine patients with chronic HBV infection who under-went heart transplantation were investigated. HBV surface/core-promoter/precore/core regions were sequenced," wrote R. Zampino and colleagues, University of Naples 2.
"Prior to transplantation, all nine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.